TriSalus Life Sciences Inc is engaged in the research, development, and sales of innovative drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product lines?Pressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.

Financial Strength

4/10

Name	Current	Vs Industry
Cash-To-Debt	2.51
Equity-to-Asset	-1.95
Debt-to-Equity	-0.05
Debt-to-EBITDA	-0.03
Piotroski F-Score	5/9	0 1 2 3 4 5 6 7 8 9
Altman Z-Score	-29.19	Distress Grey Safe
Beneish M-Score	-8.01	Manipulator Not Manipulator
WACC vs ROIC		WACC ROIC

Growth Rank

	Name	Current	Vs Industry		Vs History
	Future 3-5Y EPS without NRI Growth Rate	39.4
	Future 3-5Y Total Revenue Growth Rate	48.22

Momentum Rank

	Name	Current	Vs Industry		Vs History
	5-Day RSI	60.43
	9-Day RSI	47.52
	14-Day RSI	40.42
	6-1 Month Momentum %	-18.54

Liquidity Ratio

	Name	Current	Vs Industry		Vs History
	Current Ratio	0.92
	Quick Ratio	0.71
	Cash Ratio	0.28
	Days Inventory	258.78
	Days Sales Outstanding	48.38
	Days Payable	410.69

Dividend & Buy Back

	Name	Current	Vs Industry		Vs History
	Shareholder Yield %	-1.7

Profitability Rank

1/10

	Name	Current	Vs Industry		Vs History
	Gross Margin %	86.74
	Operating Margin %	-253.44
	Net Margin %	-291.08
	FCF Margin %	-135.29
	ROA %	-281.09
	ROIC %	-364.86
	ROC (Joel Greenblatt) %	-1971.43
	ROCE %	-1519.02

GF Value Rank

	Name	Current	Vs Industry		Vs History
	PS Ratio	5.47
	EV-to-EBIT	-2.62
	EV-to-Forward-EBIT	-3.69
	EV-to-EBITDA	-2.64
	EV-to-Forward-EBITDA	-4.17
	EV-to-Revenue	7.63
	EV-to-Forward-Revenue	5.62
	EV-to-FCF	-5.64
	Earnings Yield (Greenblatt) %	-38.17
	FCF Yield %	-17.49

GF Value

TLSI

Warning Signs

Warning! GuruFocus detected 3 Severe warning signs with TLSI. Try a 7-Day Free Trial to check it out.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.